If this works out it could be a watershed moment.
We have recently been providing this newer class of pain med utililiziing sodium channel blockers. There’s a lot of downsides to narcotics. Hoping these meds help a lot of people in need
Journavx is the brand name for the drug suzetrigine, a non-opioid medication approved by the FDA for treating moderate-to-severe acute pain in adults. It is a sodium channel blocker that inhibits pain signals without the addiction risk associated with opioids. Common side effects include itching, muscle spasms, increased creatine phosphokinase, and rash.
3 Likes